Source: Eur Respir J 2015; 46: 1255-1258



Rating:

Share or cite this content

Citations should be made in the following way:
Groh Matthieu, Pagnoux Christian, Guillevin Loïc. Eosinophilic granulomatosis with polyangiitis (formerly Churg–Strauss syndrome): where are we now?. Eur Respir J 2015; 46: 1255-1258

Member's Comments

No comment yet.

Related content which might interest you: Respiratory manifestations of eosinophilic granulomatosis with polyangiitis (Churg–Strauss) Source: Eur Respir J 2016; 48: 1429-1441 Year: 2016 Eosinophilic granulomatosis with polyangiitis Source: Eur Respir Monogr 2022; 95: 177-192 Year: 2022 Eosinophilic granulomatosis with polyangiitis Source: Eur Respir Monogr 2019; 86: 188-209 Year: 2019 Clinical manifestation, approach to diagnosis and treatment of pulmonary vasculitis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=69 Year: 2005 Anca and anti-gbm-antibodies in pulmonary-renal syndrome due to Wegener‘s granulomatosis Source: Annual Congress 2009 - Pulmonary circulation I Year: 2009 Biologics for eosinophilic granulomatosis with polyangiitis Source: Short video statement 2020 Year: 2020 Risk of acute arterial and venous thromboembolic events in eosinophilic granulomatosis with polyangiitis (Churg–Strauss syndrome) Source: Eur Respir J, 57 (5) 2004158; 10.1183/13993003.04158-2020 Year: 2021 New biomarkers for early diagnosis of eosinophilic granulomatosis with polyangiitis (EGPA) Source: International Congress 2017 – Techniques to treat asthma Year: 2017 Granulomatosis with polyangiitis (Wegener&s) Source: Eur Respir Mon 2011; 54: 1-14 Year: 2011 Frequency of eosinophilic granulomatosis with polyangiitis in Europe by meta-analysis Source: Virtual Congress 2020 – Prevalence and incidence of chronic lung diseases Year: 2020 Churg-Strauss's syndrome and eosinophilic polyserositis Source: Eur Respir J 2002; 20: Suppl. 38, 65s Year: 2002 Classification and new developments in the pathogenesis of vasculitis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-39-1, page=50 Year: 2005 Pulmonary hypertension as the first manifestation in a patient with granulomatosis with polyangiitis Source: International Congress 2019 – Pulmonary vascular diseases? Year: 2019 Steroid-sparing effects of benralizumab in patients with eosinophilic granulomatosis with polyangiitis Source: ERJ Open Res, 6 (4) 00451-2020; 10.1183/23120541.00451-2020 Year: 2020 Coexistent granulomatosis with polyangiitis (Wegener‘s) and Crohn disease: A clinicopathologic description of cases Source: Annual Congress 2012 - Pulmonary manifestations of systemic diseases Year: 2012 Microscopic polyangiitis and granulomatosis with polyangiitis Source: Eur Respir Monogr 2019; 86: 153-172 Year: 2019 Different disease subtypes in allergic eosinophilic granulomatosis with polyangiitis (EGPA) Source: Annual Congress 2013 –Clinical management of orphan lung diseases Year: 2013 Horner‘s syndrome in Wegener‘s granulomatosis: case report Source: Eur Respir J 2007; 30: Suppl. 51, 87s Year: 2007 Lung-limited Granulomatosis with polyangiitis (GPA) managed without immunosuppression Source: International Congress 2018 – CC5 Pulmonary vasculitis: the great chameleon Year: 2018